![Jeffrey Brill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Brill
No open positions remaining
Profile
Jeffrey Brill worked as an Associate Director of Clinical Development at Ascenta Therapeutics, Inc. from 2005 to 2017.
Prior to that, he worked as a Principal at Labcorp Drug Development, Inc. and Gemin X Pharmaceuticals US, Inc. Mr. Brill received his undergraduate degree from the University of Delaware.
Former positions of Jeffrey Brill
| Companies | Position | End |
|---|---|---|
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer | Corporate Officer/Principal | 31/12/2017 |
| COVANCE INC. | Corporate Officer/Principal | - |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Corporate Officer/Principal | - |
Training of Jeffrey Brill
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Develops cancer therapeutic products | Health Technology |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer | Health Technology |
- Stock Market
- Insiders
- Jeffrey Brill
